BioCentury
ARTICLE | Clinical News

IoGen: Completed Phase III enrollment

June 25, 2007 7:00 AM UTC

SYMBA completed enrollment of 145 patients in a U.S. Phase III trial of IoGen to treat moderate to severe pain associated with FBD. ...